Chicago-Area Hospital Now Offers MRI-Guided Biopsies to Diagnose If Breast Abnormalities Are Cancerous
Posted on: Wednesday, 1 October 2008, 09:00 CDT
EVERGREEN PARK, Ill., Oct. 1 /PRNewswire/ -- Radiologists at Little Company of Mary Hospital, helping to diagnose breast cancer in women, are now performing MRI-guided breast biopsies in addition to other image-guided breast biopsy procedures.
Once a lump or abnormality is detected in a patient's breast during the course of a routine physical examination, mammogram, or other imaging study, a breast biopsy may be ordered to determine whether the growth is benign or cancerous. During a biopsy a needle is inserted into suspicious tissue in the patient's breast in order to remove a small sample. Image-guided breast biopsies help physicians performing the procedures locate abnormalities that may be too small to be felt.
MRI-guided breast biopsies utilize magnetic resonance imaging, a technique that has been commonly used by physicians to diagnose other medical conditions for nearly 30 years, to help diagnosticians guide their instruments into breast abnormalities that are too small to be seen even by mammogram or ultrasound. Unlike stereotactic biopsy, MRI-guided breast biopsy does not expose patients to any radiation.
According to Dr. Olga Ivanov, the only fellowship-trained female breast surgeon in Chicago's Southwest area and medical director of Little Company's Comprehensive Breast Health Center, "Not every cancer can be detected by a mammogram. If the cancer cannot be seen on a mammogram, we cannot biopsy it with a stereotactic procedure."
Patients undergoing MRI-guided breast biopsies are subject to no other risks or side effects than those undergoing more traditional procedures. According to Kate Erickson, B.S., RT(R)(MR)(CT) supervisor of Little Company's MRI Department, "There is a lot of confusion about magnetic resonance imaging. There is no radiation involved with MRI. Even so, we sense some patients need an extra bit of reassurance, and we provide that."
At Little Company of Mary, all of the providers working on a patient's case -- from radiologists to pathologists to medical oncologists and surgeons -- work together as a comprehensive, integrated team to most effectively diagnose (and in instances where a growth is found to be cancerous, to treat) the patient's condition. "Every woman needs a truly individualized treatment plan, and at Little Company we provide that," Dr. Ivanov said. "Little Company is a very compassionate place," Erickson added. "I get so many comments from patients who feel like they're not forgotten when they come here."
Little Company has developed a Web site (http://www.pursuingpainfreecancer.org/breastcancer) to help women learn about breast cancer and evaluate their own breast cancer risk. Knowing one's risk can significantly improve a woman's chance for surviving breast cancer. The size of a breast cancer and how far it has spread are the most important factors in predicting a patient's prognosis. The earlier breast cancer is found, the better the chances that treatment will work.
To learn more about Little Company of Mary and its expert teams of surgeons, oncologists, and diagnostic radiologists, or to take the free breast cancer risk test, visit http://www.pursuingpainfreecancer.org/breastcancer .
For more information, contact: Kelly Cusack kcusack@lcmh.org (708)229-5049
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com/.
Little Company of Mary Hospital
CONTACT: Kelly Cusack of Little Company of Mary Hospital,+1-708-229-5049
Web site: http://www.pursuingpainfreecancer.org/breastcancer
Source: PRNewswire
Related Articles
- More Women Choosing To Remove Healthy Breast After Cancer Diagnosis
- The Report Will Not Only Provide A Framework But Also A Careful Identification And Evaluation Of Breast Prostate Cancer Drug Candidates, Technologies And Competitors
- REMINDER: ORLive Presents MRI-Guided Brain Tumor Removal With Cortical Mapping Received "Official Honoree" Distinction for the 11th Annual Webby Awards
- Data Show Geron's Telomerase Inhibitor Cancer Drug is Active Against Cancer Stem Cells From Multiple Myeloma Patients
- REMINDER: ORLive Presents: MRI-Guided Brain Tumor Removal With Cortical Mapping
- ORLive Presents: MRI-Guided Brain Tumor Removal With Cortical Mapping
- Breast-Ovarian Cancer Syndrome Ups Risk
- Mainstreaming of MRI-Guided Breast Biopsy Raises Demand for Dedicated MRI System
- Siemens and Haifu Collaborate to Advance Tumor Treatment; New MRI-Guided HIFU Improves Ultrasound Therapy
User Comments (0)

RSS Feeds